325 related articles for article (PubMed ID: 25879342)
41. [Application value of reduced field intensity modulated radiation therapy for advanced cervical cancer].
DU XL; Sheng XG; Wang C; Yu H; Song QQ; Pan CX
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):925-31. PubMed ID: 24506963
[TBL] [Abstract][Full Text] [Related]
42. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
[TBL] [Abstract][Full Text] [Related]
43. Radiation-induced acute toxicities after image-guided intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with spinal metastases (IRON-1 trial) : First results of a randomized controlled trial.
Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; El Shafie R; Nicolay NH; Debus J; Rief H
Strahlenther Onkol; 2018 Oct; 194(10):911-920. PubMed ID: 29978307
[TBL] [Abstract][Full Text] [Related]
44. The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer.
Al-Mamgani A; van Rooij P; Verduijn GM; Mehilal R; Kerrebijn JD; Levendag PC
Laryngoscope; 2013 Feb; 123(2):386-93. PubMed ID: 23404489
[TBL] [Abstract][Full Text] [Related]
45. Evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literature.
Besson N; Pernin V; Zefkili S; Kirova YM
Br J Radiol; 2016; 89(1059):20150409. PubMed ID: 26744079
[TBL] [Abstract][Full Text] [Related]
46. A dosimetric analysis of tomotherapy based intensity modulated radiation therapy with and without bone marrow sparing in gynecologic malignancies.
Platta CS; Bayliss A; McHaffie D; Tome WA; Straub MR; Bradley KA
Technol Cancer Res Treat; 2013 Feb; 12(1):19-29. PubMed ID: 22974331
[TBL] [Abstract][Full Text] [Related]
47. A dosimetric analysis of intensity-modulated radiation therapy with bone marrow sparing for cervical cancer.
Murakami N; Okamoto H; Kasamatsu T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Toita T; Ito Y; Itami J
Anticancer Res; 2014 Sep; 34(9):5091-8. PubMed ID: 25202097
[TBL] [Abstract][Full Text] [Related]
48. [Clinical research on the treatment of patients with cervical carcinoma using three-dimensional conformal radiotherapy].
Che SM; Liu Z; Chen HW; Zheng W; Su J; Gao Y; Yang YY
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):727-9. PubMed ID: 18307895
[TBL] [Abstract][Full Text] [Related]
49. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression.
van de Bunt L; van der Heide UA; Ketelaars M; de Kort GA; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):189-96. PubMed ID: 15978745
[TBL] [Abstract][Full Text] [Related]
50. A prospective, comparative analysis of acute toxicity profile between three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT) in locally advanced head and neck cancer patients.
Kucha N; Soni TP; Jakhotia N; Patni N; Singh DK; Gupta AK; Sharma LM; Goyal J
Cancer Treat Res Commun; 2020; 25():100223. PubMed ID: 33120316
[TBL] [Abstract][Full Text] [Related]
51. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
Liao ZX; Komaki RR; Thames HD; Liu HH; Tucker SL; Mohan R; Martel MK; Wei X; Yang K; Kim ES; Blumenschein G; Hong WK; Cox JD
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):775-81. PubMed ID: 19515503
[TBL] [Abstract][Full Text] [Related]
52. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
[TBL] [Abstract][Full Text] [Related]
53. Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomes.
Appel S; Bar J; Ben-Nun A; Perelman M; Alezra D; Urban D; Ben-Ayun M; Honig N; Ofek E; Katzman T; Onn A; Chatterji S; Dubinski S; Tsvang L; Felder S; Kraitman J; Haisraely O; Rabin Alezra T; Lieberman S; Marom EM; Golan N; Simansky D; Symon Z; Lawrence YR
Br J Radiol; 2019 May; 92(1097):20180960. PubMed ID: 30864828
[TBL] [Abstract][Full Text] [Related]
54. Hypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancer.
Alongi F; Cozzi L; Fogliata A; Iftode C; Comito T; Clivio A; Villa E; Lobefalo F; Navarria P; Reggiori G; Mancosu P; Clerici E; Tomatis S; Taverna G; Graziotti P; Scorsetti M
Anticancer Res; 2013 Oct; 33(10):4537-43. PubMed ID: 24123027
[TBL] [Abstract][Full Text] [Related]
55. Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT.
Albuquerque K; Giangreco D; Morrison C; Siddiqui M; Sinacore J; Potkul R; Roeske J
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1043-7. PubMed ID: 20471182
[TBL] [Abstract][Full Text] [Related]
56. Integral dose in three-dimensional conformal radiotherapy, intensity-modulated radiotherapy and helical tomotherapy.
Yang R; Xu S; Jiang W; Xie C; Wang J
Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):706-12. PubMed ID: 19713087
[TBL] [Abstract][Full Text] [Related]
57. 3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.
Wendt TG; Abbasi-Senger N; Salz H; Pinquart I; Koscielny S; Przetak SM; Wiezorek T
Radiat Oncol; 2006 Jun; 1():18. PubMed ID: 16790059
[TBL] [Abstract][Full Text] [Related]
58. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study.
Chan P; Yeo I; Perkins G; Fyles A; Milosevic M
Radiat Oncol; 2006 May; 1():13. PubMed ID: 16722546
[TBL] [Abstract][Full Text] [Related]
59. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
[TBL] [Abstract][Full Text] [Related]
60. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
Mell LK; Kochanski JD; Roeske JC; Haslam JJ; Mehta N; Yamada SD; Hurteau JA; Collins YC; Lengyel E; Mundt AJ
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1356-65. PubMed ID: 16757127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]